Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In Phase 2 trials over 48 weeks, participants at the 12mg dose achieved an average of 24.2% body weight reduction, outpacing both Semaglutide (14.9%) and Tirzepatide (20.9%) in comparative data
Ignoring Micronutrients: Reduced food intake risks vitamin and mineral deficiencies causing fatigue, hair loss, and weakened immunity
Do not throw them in the regular trash or flush them down the toilet
- Ultra-thin characteristics, light weight, flexible size, flexible shapes, and ability to accommodate many applications
If retatrutide shows cardiovascular benefit similar to or better than semaglutide, it would significantly strengthen the case for approval and potentially expand the labeled indications
Sustained-release formulations like Glutathione-SR bypass digestive breakdown, ensuring better absorption and consistent cellular protection
